Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATELIER: Atezolizumab +/- Cobimetinib in Liver Metastases from CRC
NCT03340558Phase 2Withdrawn
- Sponsor
- Niharika Mettu
- Start
- May 2018
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cobimetinib in colorectal cancer (metastatic) (mCRC), sponsored by Niharika Mettu. Planned start May 2018; status: withdrawn.
02
Drugs
cobimetinib
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT03340558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340558.